Navigation Links
AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles

terially from those in the forward-looking statements. Such risks and uncertainties include, among others, the ability of AEterna Zentaris to implement its business strategies, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of AEterna Zentaris to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements.

CONTACT: Jenene Thomas, Senior Director, Investor Relations & CorporateCommunications, (418) 655-6420, ; PaulBurroughs, Media Relations (418) 652-8525 ext. 406, jenene.thomas@aeternazentaris.com paul.burroughs@aeternazentaris.com

Ticker Symbol: (Toronto:AEZ.),(NASDAQ-NMS:AEZS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
Post Your Comments:
(Date:7/23/2014)... July 23, 2014  ACON Equity Partners III, L.P., ... L.L.C. ("ACON") announced it has completed the purchase of ... Audax Group and Parthenon Capital Partners. IWP is a ... Workers, Compensation, Automobile Personal Injury Protection and Personal Injury ... . As part of this transaction, ...
(Date:7/23/2014)... , July 23, 2014  ArmaGen, a ... therapies to treat severe neurological disorders, announced today ... and collaboration agreement with Shire plc to develop ... potential treatment of both the central nervous system ... Also known as MPS II, Hunter syndrome is ...
(Date:7/23/2014)... 2014 Research and Markets ... - Global Strategic Business Report" report to ... This report analyzes the worldwide ... Thousands by the following Product Segments: Lecithin, Monoglycerides, ... Sorbitan Esters, and Polyglycin Polyricinoleate & Others. The ...
Breaking Medicine Technology:ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Emulsifiers - Global Strategic Business Report: Updated 2014 Report 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 3
(Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
(Date:7/23/2014)... Ticket Down is reliable source for cheap ... at the Cotton Bowl. The 2014 Guinness International Champions ... States and Canada beginning on July 24. The tournament features ... Serie A, English Premier League, and Superleague Greece. Among the ... Inter Milan, Liverpool, AS Roma, and Real Madrid. The latter ...
(Date:7/23/2014)... report defines and segments the "EHV Transmission Market by ... Africa, and Americas) - Global Trends & Forecasts to ... of the global revenue. The global EHV transmission market ... 2014 to nearly $14 billion by 2019 at a ... Tables and 10 Figures Spread Through 220 Pages On ...
(Date:7/23/2014)... Absolute PhysioCare and Sports Rehab, a Burnaby orthotics ... orthotics and gait scan analysis that will be focused ... restore normal body balance. This treatment can reduce stress ... In addition, Custom orthotics provides shock absorption, extra cushioning, ... relief and greater comfort while walking, running, or playing ...
(Date:7/23/2014)... Creek, MI (PRWEB) July 23, 2014 ... program that gets clients off to a great start ... can believe in, has launched a new Internet Addiction ... “Many people are surprised to learn that Internet addiction ... addiction or drug addiction, but that it’s trapping more ...
Breaking Medicine News(10 mins):Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2
... MOUNTAIN VIEW, Calif., March 6 Alexza Pharmaceuticals, Inc. (Nasdaq: ... results for its fiscal year ended December 31, 2008, on ... financial markets. The Company will host an investor conference ... updates at 4:30 p.m. Eastern Time the same day. ...
... saves about $722 per patient , , FRIDAY, March 6 ... diagnosing and treating obstructive sleep apnea (OSA) is as ... physicians and sleep studies, according to Australian researchers. ... more breathing interruptions an hour while they sleep. The ...
... Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX), today ... of St. Francis Health Services, Inc. (SSFHS) has adopted ... of Indiana. The Northern Indiana region of the ... Anthony Medical Center, Crown Point; Saint Anthony Memorial, Michigan ...
... Medical Center (HCMC) will celebrate 122 years of innovation ... (CME) Event and Celebration at the Depot in Downtown ... a gathering of historic proportions, HCMC alumni, colleagues, and ... experiences at HCMC while enjoying the best of downtown ...
... are helping to write the operating manual for the ... apparatus is called a spindle because it looks like ... spindle fibers sticking out. The lengthening and shortening of ... chromosome pairs. , Understanding how this machine accurately ...
... 6 Versus Technology,Inc. ("Versus" or the "Company") (OTC ... quarter ended January 31, 2009, a 13% increase over,revenues ... The growth in revenue is,attributable, in part, to more ... of service revenues. Versus, quarterly revenues can vary,significantly ...
Cached Medicine News:Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 2Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 3Health News:Simpler Sleep Apnea Treatment Seems Effective, Affordable 2Health News:Patient Safety Technologies, Inc. Announces the Adoption of the Safety-Sponge(TM) System by the First Hospital in the State of Indiana 2Health News:Best of Hennepin to Celebrate Hennepin's Best 2Health News:Molecule tracking reveals mechanism of chromosome separation in dividing cells 2Health News:Molecule tracking reveals mechanism of chromosome separation in dividing cells 3Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6
... is a fully automated, user-friendly system ... labor resources and improve patient care. ... and immunoturbidimetric testing capabilities with a ... assays. It's also a powerful, intuitive ...
... produced with recombinant technology, that have been fully ... of detecting the different types of T.cruzi that ... amino acid sequences repeated in tandem. SAPA (shed ... of the infection, it reacts with 93% of ...
Inquire...
... Subcutaneous Lead System Model 6996 ... the use of the Medtronic ... SQ design and implant technique ... and easy procedure, and high ...
Medicine Products: